Evidence map›Paper›PMID 33040014›Full record

ArticleBMJ open2020

Availability of equipment and medications for non-communicable diseases and injuries at public first-referral level hospitals: a cross-sectional analysis of service provision assessments in eight low-income countries.

Neil Gupta, Matthew M Coates, Abebe Bekele, Roodney Dupuy, Darius Leopold Fénelon, Anna D Gage, Theodros Getachew, Biraj Man Karmacharya, Gene F Kwan, Aimée M Lulebo and 8 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Satisfaction with clinical practice environments among early-career health professionals in South Africa: findings from the WiSDOM cohort study.International journal for quality in health care : journal of the International Society for Quality in Health Care · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Neil GuptaProgram in Global Noncommunicable Disease and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.ORCID 0000-0003-3470-5351
Matthew M CoatesProgram in Global Noncommunicable Disease and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-8474-4992
Abebe BekeleHealth System and Reproductive Health Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Roodney DupuyLe Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti.
Darius Leopold FénelonZanmi Lasante, Port-au-Prince, Haiti.
Anna D GageDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Theodros GetachewHealth System and Reproductive Health Research Directorate, Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
Biraj Man KarmacharyaDepartment of Community Medicine, Kathmandu University School of Medical Sciences, Kathmandu, Nepal.
Gene F KwanProgram in Global Noncommunicable Disease and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-0929-6800
Aimée M LuleboKinshasa School of Public Health, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Jones K MasiyeMalawi Ministry of Health, Lilongwe, Malawi.
Mary Theodory MayigeNational Institute for Medical Research, Dar es Salaam, Tanzania.
Maïmouna Ndour MbayeDepartment of Internal Medicine, University Hospital Center of Dakar, Cheikh Anta Diop University, Dakar, Senegal.
Malay Kanti MridhaCenter for Non-communicable Diseases and Nutrition, BRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.ORCID 0000-0001-9226-457X
Paul H ParkProgram in Global Noncommunicable Disease and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.
Wubaye Walelgne DagnawPartners In Health, Boston, Massachusetts, USA.
Emily B WroeProgram in Global Noncommunicable Disease and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA.
Gene BukhmanProgram in Global Noncommunicable Disease and Social Change, Harvard Medical School Department of Global Health and Social Medicine, Boston, Massachusetts, USA Gene_Bukhman@hms.harvard.edu.ORCID 0000-0003-4500-7903

Funding

Identifying facilitators and barriers to heart failure care in Haiti to adapt a community-based interventionK23HL140133 · NHLBI · BOSTON MEDICAL CENTER · PI KWAN, GENE FAZIL · 2019 to 2022
$663k
NHLBI NIH HHS K23 HL140133
6 · The paper itself

Abstract

CONTEXT AND

objectivesNon-communicable diseases and injuries (NCDIs) comprise a large share of mortality and morbidity in low-income countries (LICs), many of which occur earlier in life and with greater severity than in higher income settings. Our objective was to assess availability of essential equipment and medications required for a broad range of acute and chronic NCDI conditions.

designSecondary analysis of existing cross-sectional survey data.

settingWe used data from Service Provision Assessment surveys in Bangladesh, the Democratic Republic of the Congo, Ethiopia, Haiti, Malawi, Nepal, Senegal and Tanzania, focusing on public first-referral level hospitals in each country. OUTCOME MEASURES: We defined sets of equipment and medications required for diagnosis and management of four acute and nine chronic NCDI conditions and determined availability of these items at the health facilities.

resultsOverall, 797 hospitals were included. Medication and equipment availability was highest for acute epilepsy (country estimates ranging from 40% to 95%) and stage 1-2 hypertension (28%-83%). Availability was low for type 1 diabetes (1%-70%), type 2 diabetes (3%-57%), asthma (0%-7%) and acute presentations of diabetes (0%-26%) and asthma (0%-4%). Few hospitals had equipment or medications for heart failure (0%-32%), rheumatic heart disease (0%-23%), hypertensive emergencies (0%-64%) or acute minor surgical conditions (0%-5%). Data for chronic pain were limited to only two countries. Availability of essential medications and equipment was lower than previous facility-reported service availability.

conclusionsOur findings demonstrate low availability of essential equipment and medications for diverse NCDIs at first-referral level hospitals in eight LICs. There is a need for decentralisation and integration of NCDI services in existing care platforms and improved assessment and monitoring to fully achieve universal health coverage.

Indexed as

Diabetes Mellitus, Type 2Noncommunicable DiseasesAdultBangladeshCross-Sectional StudiesEthiopiaHaitiHospitals, PublicHumansMalawiNepalReferral and ConsultationSenegalTanzaniaasthmacardiologydiabetes & endocrinologyhealth policysurgerytropical medicine

Identifiers

PMID33040014
PMCPMC7549470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.